Indraprastha Apollo Hospital offers specialized Immunotherapy supported by experienced oncology specialists, advanced treatment technology, and structured patient monitoring. Established in 1996, the JCI accredited hospital is situated in Delhi, India and has 710 beds with comprehensive cancer treatment infrastructure.

Immunotherapy may be recommended for selected patients when the cancer has specific characteristics that make it responsive to immune-based treatment. Certain medicines work by removing inhibitory signals that prevent immune cells from attacking cancer, while others target specific immune pathways or cancer-associated proteins. Treatment is usually administered according to a planned schedule, with patients monitored for fatigue, skin reactions, inflammation, and other potential immune-related effects.